Starbucks (Nasdaq: SBUX) is turning its coffee shops into a test
lab from which to launch new grocery store products to hawk.

Chart Courtesy of StockCharts.com
Howard Schulz is back at the helm of Starbucks. And that
means that ideas, concepts, strategies, and perhaps better
performance for the stock may lie ahead.
To be sure, Mr. Schulz may come down with a case of Michael Dell disease, meaning
that his return from a sabbatical may not have been a good idea. But, so far,
Schulz's return hasn't been bad for the coffee giant.
His store closings, and tightening of the purse have helped the company's bottom
line. The problem with Starbucks, though, aside from incresing competition, is
the economy. It's hard to sell expensively perceived coffee during hard times.
Which is where the new products and the grocery store outlets seem to come into
the picture. The Via instant coffee line had $100 million in sales last year
and is now sold in supermarkets, expanding its potential reach.
Schulz is also ramping up more Via products, expanding the Tazo tea line, and
trying to expand the reach of the Seattle's Best Coffee product line as well
as expanding the use of its grocery store based outlets as a place where customers
can sample new products and then get them off the store shelves.
It's all two yards and a cloud of dust type stuff. But in this economy, it makes
sense. We'll be watching the shares in the next few days. On 8-18, they found
support at the 200-day moving average after their recent decline.
That suggests that value money, long term investors (there may be some left out
there) may be nibbling.
Follow Dr. Duarte on Twitter
Make money if any market rises or falls, with a copy of "Market Timing For Dummies."
“Futures And Options For Dummies,” Dr. Duarte’s
latest book is now available. The markets are responding to news
and geopolitical developments like never before. In this environment,
individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons)
has an excellent section on oil futures as well as the currency markets,
while covering and expanding on the successful strategies in Doctor
Duarte's other books. Order your copy today.
Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.
He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."
In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.
In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.
He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.
One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.
His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.
In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.
Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.
|